Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 15
1991 92
1992 267
1993 391
1994 531
1995 551
1996 583
1997 597
1998 596
1999 534
2000 561
2001 485
2002 437
2003 404
2004 356
2005 329
2006 287
2007 265
2008 259
2009 207
2010 246
2011 224
2012 154
2013 125
2014 169
2015 110
2016 92
2017 73
2018 43
2019 35
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

8,707 results
Results by year
Filters applied: . Clear all
Page 1
Genetic Modifiers of the p53 Pathway.
Basu S, Murphy ME. Basu S, et al. Cold Spring Harb Perspect Med. 2016 Apr 1;6(4):a026302. doi: 10.1101/cshperspect.a026302. Cold Spring Harb Perspect Med. 2016. PMID: 27037420 Free PMC article. Review.
CRISPR-Cas9-based target validation for p53-reactivating model compounds.
Wanzel M, Vischedyk JB, Gittler MP, Gremke N, Seiz JR, Hefter M, Noack M, Savai R, Mernberger M, Charles JP, Schneikert J, Bretz AC, Nist A, Stiewe T. Wanzel M, et al. Nat Chem Biol. 2016 Jan;12(1):22-8. doi: 10.1038/nchembio.1965. Epub 2015 Nov 23. Nat Chem Biol. 2016. PMID: 26595461 Free PMC article.
Isolation of p53-target genes and their functional analysis.
Nakamura Y. Nakamura Y. Cancer Sci. 2004 Jan;95(1):7-11. doi: 10.1111/j.1349-7006.2004.tb03163.x. Cancer Sci. 2004. PMID: 14720320 Free article. Review.
Somatic TP53 variants frequently confound germ-line testing results.
Weitzel JN, Chao EC, Nehoray B, Van Tongeren LR, LaDuca H, Blazer KR, Slavin T, Facmg DABMD, Pesaran T, Rybak C, Solomon I, Niell-Swiller M, Dolinsky JS, Castillo D, Elliott A, Gau CL, Speare V, Jasperson K. Weitzel JN, et al. Genet Med. 2018 Aug;20(8):809-816. doi: 10.1038/gim.2017.196. Epub 2017 Nov 30. Genet Med. 2018. PMID: 29189820 Free PMC article.
8,707 results
Jump to page
Feedback